Value of Urodynamics Prior to Stress Incontinence Surgery (VUSIS)
Primary Purpose
Stress Urinary Incontinence
Status
Terminated
Phase
Not Applicable
Locations
Netherlands
Study Type
Interventional
Intervention
Urodynamics
Sponsored by
About this trial
This is an interventional diagnostic trial for Stress Urinary Incontinence focused on measuring stress urinary incontinence, urodynamics, randomized clinical trial, surgery
Eligibility Criteria
Inclusion Criteria:
- Symptoms of stress urinary incontinence and/or mixed urinary incontinence, predominantly stress incontinence
- Signs of stress urinary incontinence on physical examination or voiding-diary
- Patient is a candidate for surgical treatment (as based on history and physical examination)
- Patient has attended at least 3 months of physiotherapy
- Patient accepts randomisation
- Patient is capable to fill out bladder diary's, pad tests and questionnaires
- Patient understands the Dutch written and spoken language
- ASA 1 or 2
Exclusion Criteria:
- Previous incontinence surgery
- Mixed urinary incontinence, urge component is predominant
- Prolapse >= 1cm beyond the hymen on Valsalva in supine position
- Postvoid urinary residual > 150ml
- Present urinary tract infection
- The need for additional pelvic surgery (prolapse and/or hysterectomy)
- Patient is or wants to become pregnant
- Prior pelvic radiotherapy
Sites / Locations
- UMC St.Radboud
Outcomes
Primary Outcome Measures
Non inferiority among the two groups as far as the improvement in the UDI at two years after treatment is concerned.
Secondary Outcome Measures
Cure of incontinence as measured by the pad test and voiding diary. Complications of surgery for stress urinary incontinence, in particular re-operations and overactive bladder symptoms. Quality of life as measured by RAND-36, Euroqol and IIQ.
Full Information
NCT ID
NCT00509730
First Posted
July 30, 2007
Last Updated
October 6, 2009
Sponsor
Radboud University Medical Center
Collaborators
ZonMw: The Netherlands Organisation for Health Research and Development
1. Study Identification
Unique Protocol Identification Number
NCT00509730
Brief Title
Value of Urodynamics Prior to Stress Incontinence Surgery
Acronym
VUSIS
Official Title
Multicentered Randomized Controlled Trail to Test the Cost Effectiveness of Urodynamics in Women With Symptoms of Stress Urinary Incontinence in Whom Surgical Treatment is Considered
Study Type
Interventional
2. Study Status
Record Verification Date
June 2008
Overall Recruitment Status
Terminated
Study Start Date
March 2007 (undefined)
Primary Completion Date
undefined (undefined)
Study Completion Date
March 2010 (Anticipated)
3. Sponsor/Collaborators
Name of the Sponsor
Radboud University Medical Center
Collaborators
ZonMw: The Netherlands Organisation for Health Research and Development
4. Oversight
Data Monitoring Committee
Yes
5. Study Description
Brief Summary
To test the value of preoperatively performed urodynamics with regard to outcome of surgery for stress urinary incontinence (SUI) and to examine whether not performing urodynamics preoperatively is more cost effective than performing urodynamics preoperatively using the non-inferiority assumption.
Detailed Description
Design: multidisciplinary and multicentre randomized controlled trial
Study population/inclusion criteria : all women, not previously operated for stress incontinence, seeking help for urinary stress incontinence where conservative therapy in particular physiotherapy has failed and are opting and candidates for surgical therapy will be asked to participate in our study. Incontinence must have been demonstrated on physical examination and/or micturition diary. Patients can be included by gynaecologists or urologists who are cooperating in the study.
Intervention: consists of the non performance of urodynamics in the studygroup. The control group will undergo urodynamics as is at present the norm.
In all patients the next items will be recorded at inclusion:
History and clinical examination
48h-Bladder(voiding and incontinence) diary,
48h-Pad test
Validated Quality of Life questionnaires (SF 36, Euroqol 5D, UDI, IIQ)
Urinalysis for the detection of urinary tract infection.
Residual urine measured by ultrasound.
At this point an interim decision will be made for surgery. At that moment patients are informed about the study. After obtaining informed consent the patients are randomly assigned to undergo urodynamic testing or not. In the study group the decision for intervention will be based on the history and clinical examination only and will be the same as the interim decision which is surgery.
In the control group this decision will be based on history and clinical examination IN COMBINATION with the result of the urodynamic testing. It can be a decision to proceed with surgery (estimated at 2/3rd of the women) or conservative usually medication. The T0(moment of intervention) is defined as the moment of the first intervention which is by definition surgery in the study group and either surgery or conservative in the control group. After the intervention additional therapy is possible in both arms.
The follow-up period will be 24 months after T0 , in which the same parameters as pre-operative will be assessed.
These items will be assessed at:
6 weeks post intervention (PI) 3 months PI 6 months PI 12 months PI 24 months PI
Urodynamics, in the control group, will be performed according to ICS standards and consist of free flow, fillingscystometry, pressure flow study and a urethral pressure profilometry in rest and during stress. The outcomes will be matched to urodynamic findings to indicate the possible useful parts of the urodynamic findings.
Post operative urodynamics is NOT part of the study.
The primary outcome of this study is the improvement of Urogenital Distress Inventory (UDI) at 24 months after baseline and the power calculation is performed using the non-inferiority assumption. The mean improvement in UDI in both groups is expected to be 35 with standard deviation 10.(22) A difference in mean improvement of 8 or less is considered non-inferior. As this condition is allowed for one third of the total group (those women in the non-UDI group, who would not have been operatively treated), this results in a difference in mean improvement of 2.7 or less between the UDI and non-UDI group. Then effectively 130 women in each group are needed to reach a power of 70% using one-sided testing at 0.05. Considering an expected percentage lost to follow up of ca. 10%, in total 290 women (145 in each group) will be included in this study.
Multivariate analysis of covariance with group, centre and the baseline covariate as independent variables will be used to estimate differences in improvement of the UDI after 24 months between the groups with 95% confidence intervals. As the UDI is skewed, data will be logtransformed prior to analysis. Other variables (ie Incontinence Impact Questionnaire) will be analysed similar.
Economic evaluation:
For each patient, utilisation of health care services will be recorded prospectively, using Case Record Forms, including urodynamic testing, surgery for SUI, re-operations, medical treatment for detrusor instability, care for urinary incontinence, and care for urinary retention. By multiplying these volumes of care with unit cost prices, direct medical costs incurred by SUI during the follow up period will be calculated for each patient. For unit cost prices, national guidelines will be used (CVZ, 2004). For costs of care for urinary incontinence and urinary retention, data from the literature will be used, converted to 2006 prices. We incorporated the health related quality of life questionnaire euroqol 5D in our study to be able to calculate QALYs (quality-adjusted life-years), which is a measure of health outcomes. A QALY is the change in quality of life induced by the treatment multiplied by the duration of the treatment effect and it provides the number of QALYs gained. QALYs can then be related to medical costs to arrive at a final common denominator of cost/QALY. This parameter can be used to compare the cost-effectiveness of the treatment.
6. Conditions and Keywords
Primary Disease or Condition Being Studied in the Trial, or the Focus of the Study
Stress Urinary Incontinence
Keywords
stress urinary incontinence, urodynamics, randomized clinical trial, surgery
7. Study Design
Primary Purpose
Diagnostic
Study Phase
Not Applicable
Interventional Study Model
Factorial Assignment
Masking
None (Open Label)
Allocation
Randomized
Enrollment
290 (Anticipated)
8. Arms, Groups, and Interventions
Intervention Type
Procedure
Intervention Name(s)
Urodynamics
Primary Outcome Measure Information:
Title
Non inferiority among the two groups as far as the improvement in the UDI at two years after treatment is concerned.
Secondary Outcome Measure Information:
Title
Cure of incontinence as measured by the pad test and voiding diary. Complications of surgery for stress urinary incontinence, in particular re-operations and overactive bladder symptoms. Quality of life as measured by RAND-36, Euroqol and IIQ.
10. Eligibility
Sex
Female
Accepts Healthy Volunteers
Accepts Healthy Volunteers
Eligibility Criteria
Inclusion Criteria:
Symptoms of stress urinary incontinence and/or mixed urinary incontinence, predominantly stress incontinence
Signs of stress urinary incontinence on physical examination or voiding-diary
Patient is a candidate for surgical treatment (as based on history and physical examination)
Patient has attended at least 3 months of physiotherapy
Patient accepts randomisation
Patient is capable to fill out bladder diary's, pad tests and questionnaires
Patient understands the Dutch written and spoken language
ASA 1 or 2
Exclusion Criteria:
Previous incontinence surgery
Mixed urinary incontinence, urge component is predominant
Prolapse >= 1cm beyond the hymen on Valsalva in supine position
Postvoid urinary residual > 150ml
Present urinary tract infection
The need for additional pelvic surgery (prolapse and/or hysterectomy)
Patient is or wants to become pregnant
Prior pelvic radiotherapy
Overall Study Officials:
First Name & Middle Initial & Last Name & Degree
Mark Vierhout, M.D. PhD.
Organizational Affiliation
University Medical Center St. Radboud
Official's Role
Principal Investigator
First Name & Middle Initial & Last Name & Degree
John Heesakkers, M.D. PhD.
Organizational Affiliation
University Medical Center St. Radboud
Official's Role
Principal Investigator
First Name & Middle Initial & Last Name & Degree
Suzan Broekhuis, M.D.
Organizational Affiliation
University Medical Center St. Radboud
Official's Role
Principal Investigator
Facility Information:
Facility Name
UMC St.Radboud
City
Nijmegen
State/Province
Gelderland
ZIP/Postal Code
6500 H.B.
Country
Netherlands
12. IPD Sharing Statement
Citations:
PubMed Identifier
22488817
Citation
van Leijsen SA, Kluivers KB, Mol BW, Broekhuis SR, Milani AL, Bongers MY, Aalders CI, Dietz V, Malmberg GG, Vierhout ME, Heesakkers JP. Can preoperative urodynamic investigation be omitted in women with stress urinary incontinence? A non-inferiority randomized controlled trial. Neurourol Urodyn. 2012 Sep;31(7):1118-23. doi: 10.1002/nau.22230. Epub 2012 Apr 6.
Results Reference
derived
Learn more about this trial
Value of Urodynamics Prior to Stress Incontinence Surgery
We'll reach out to this number within 24 hrs